Illumina Body Map 2: averaged replicates
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXD2 | hg19_v2_chr1_+_47901689_47901689 | 0.33 | 6.9e-02 | Click! |
FOXO3 | hg19_v2_chr6_+_108977520_108977549 | 0.21 | 2.6e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 28.1 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 13.4 | GO:0031295 | T cell costimulation(GO:0031295) |
2.2 | 13.3 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.0 | 13.1 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
1.3 | 12.6 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.5 | 11.1 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.4 | 10.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 8.9 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
2.7 | 8.2 | GO:0045957 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
1.6 | 8.2 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 28.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 23.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 18.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 17.6 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 17.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 13.0 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 12.7 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 11.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 11.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 10.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 28.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 15.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 13.3 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 12.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
1.1 | 12.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 10.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 9.7 | GO:0042287 | MHC protein binding(GO:0042287) |
0.6 | 9.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 9.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 9.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 29.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 21.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 17.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 16.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 16.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.5 | 15.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 14.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 14.3 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 14.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 14.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 28.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 24.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 24.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 17.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 16.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 12.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 12.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.3 | 10.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 9.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 9.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |